Chapter 1. Introduction
|
1.1. Market Definition
|
1.2. Research Scope
|
1.2.1. Markets Covered
|
1.2.2. Years
Considered for Study
|
|
|
Chapter 2. Research Methodology
|
2.1. Research Sources
|
2.1.1. Primary
|
2.1.2. Secondary
|
2.2. Market Size
Estimation
|
|
|
Chapter 3. Executive Summary
|
3.1. Summary Snapshot
Market Size and Forecast, 2018-2029
|
3.2. Antinuclear Antibody
Test Market Share by Product Type, 2021 vs 2029 (USD Million)
|
3.3. Antinuclear Antibody
Test Market Share by Disease Type, 2021 vs 2029 (USD Million)
|
3.4. Antinuclear Antibody
Test Market Share by Technique, 2021 vs 2029 (USD Million)
|
3.5. Antinuclear Antibody
Test Market Share by End Use, 2021 vs 2029 (USD Million)
|
3.6. Antinuclear Antibody
Test Market Share by Region, 2021 vs 2029 (USD Million)
|
|
|
Chapter 4. Key Insights
|
|
|
Chapter 5. Antinuclear Antibody Test Market Segmentation & Impact
Analysis
|
5.1. Antinuclear Antibody
Test Market Indicators Analysis
|
5.1.1. Market
Drivers Analysis
|
5.1.1.1. High Incidence of Autoimmune Diseases
|
5.1.1.2. Increasing Population and Growth in Healthcare Expenditure
|
5.1.1.3. Growth in the Number of Individuals Covered Under Medical
Insurance
|
5.1.2. Market
Restraint Analysis
|
5.1.2.1. Stringent Regulations for the Approval of Medical Devices
|
5.1.2.2. Implementation of Excise Duty on Medical Devices in the U.S.
|
5.1.3. Market
Opportunity Analysis
|
5.1.3.1.
Laboratory Automation
|
5.2. Regulatory Analysis
|
5.2.1. North
America
|
5.2.1.1. U.S.
|
5.2.1.2. Canada
|
5.2.2. Europe
|
5.2.2. Asia
Pacific
|
5.2.2.1. India
|
5.2.2.2. Japan
|
5.2.2.3. China
|
5.3. Technological Insights
|
5.4. COVID-19 Impact
analysis on Antinuclear Antibody Test Market
|
5.5. Porter’s Five Forces
Analysis
|
5.5.1. Bargaining
Power of Buyers/Consumers
|
5.5.2. Bargaining
Power of Suppliers
|
5.5.3. Threat of
New Entrants
|
5.5.4. Threat of
Substitute Products
|
5.5.5. Intensity of
Competitive Rivalry
|
5.6. Competitive Metric
Space Analysis
|
|
|
Chapter 6. Antinuclear Antibody Test Market, By Product Type
(Market Size and Forecast by Value - USD Million, 2018 - 2029)
|
6.1. Antinuclear Antibody
Test Market, By Product Type (Market Size and Forecast by Value - USD
Million, 2021 & 2029)
|
6.1.1. Reagents
& Assay Kits
|
6.1.1.1. Reagents & Assay
Kits Market Estimates and Forecast, 2019-2029 (USD Million)
|
6.1.1.2. Reagents & Assay Kits Market Estimates
and Forecast, By Region, 2019-2029 (USD Million)
|
6.1.2. Systems
|
6.1.2.1. Systems Market Estimates and Forecast, 2019-2029 (USD
Million)
|
6.1.2.2. Systems Market
Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
6.1.3. Software
& Services
|
6.1.3.1. Software & Services Market Estimates and Forecast,
3019-3039 (USD Million)
|
6.1.3.2. Software
& Services Market Estimates and Forecast, By Region, 3019-3039 (USD
Million)
|
|
|
Chapter 7. Antinuclear Antibody Test Market, By Disease Type
(Market Size and Forecast by Value - USD Million, 2018 - 2029)
|
7.1. Antinuclear Antibody
Test Market, By Disease Type (Market Size and Forecast by Value - USD
Million, 2021 & 2029)
|
7.1.1. Rheumatoid
Arthritis
|
7.1.1.1. Rheumatoid Arthritis
Market Estimates and Forecast, 2019-2029 (USD Million)
|
7.1.1.2. Rheumatoid Arthritis
Market Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
7.1.2. Systemic
Lupus Erythematosus
|
7.1.2.1. Systemic Lupus
Erythematosus Market Estimates and Forecast, 2019-2029 (USD Million)
|
7.1.2.2. Systemic Lupus
Erythematosus Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
7.1.3. Sjögren’s
Syndrome
|
7.1.3.1. Sjögren’s Syndrome Market
Estimates and Forecast, 2019-2029 (USD Million)
|
7.1.3.2. Sjögren’s Syndrome Market Estimates and Forecast, By Region,
2019-2029 (USD Million)
|
7.1.4. Scleroderma
|
7.1.4.1. Scleroderma Market Estimates and Forecast, 2019-2029 (USD
Million)
|
7.1.4.2. Scleroderma Market Estimates and Forecast, By Region,
2019-2029 (USD Million)
|
7.1.5. Other
Diseases
|
7.1.5.1. Other Diseases Market Estimates and Forecast, 2019-2029 (USD
Million)
|
7.1.5.2. Other Diseases Market Estimates and Forecast, By Region,
2019-2029 (USD Million)
|
|
|
Chapter 8. Antinuclear Antibody Test Market, By Technique (Market
Size and Forecast by Value - USD Million, 2018 - 2029)
|
8.1. Antinuclear Antibody
Test Market, By Technique (Market Size and Forecast by Value - USD Million,
2021 & 2029)
|
8.1.1. ELISA
|
8.1.1.1. ELISA Market Estimates
and Forecast, 2019-2029 (USD Million)
|
8.1.1.2. ELISA Market Estimates
and Forecast, By Region, 2019-2029 (USD Million)
|
8.1.2.
Immunofluorescence Assay
|
8.1.2.1. Immunofluorescence
Assay Market Estimates and Forecast, 2019-2029 (USD Million)
|
8.1.2.2. Immunofluorescence
Assay Market Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
8.1.3. Multiplex Assay
|
8.1.3.1. Multiplex Assay Market Estimates and Forecast, 2019-2029 (USD
Million)
|
8.1.3.2. Multiplex Assay Market Estimates and Forecast, By Region,
2019-2029 (USD Million)
|
|
|
Chapter 9. Antinuclear Antibody Test Market, By End Use (Market
Size and Forecast by Value - USD Million, 2018 - 2029)
|
9.1. Antinuclear Antibody
Test Market, By End Use (Market Size and Forecast by Value - USD Million,
2021 & 2029)
|
9.1.1. Hospitals
|
9.1.1.1. Hospitals Market Estimates and Forecast, 2019-2029 (USD
Million)
|
9.1.1.2. Hospitals Market Estimates and Forecast, By Region, 2019-2029
(USD Million)
|
9.1.2. Clinical
Laboratories
|
9.1.2.1. Clinical Laboratories Market Estimates and Forecast,
2019-2029 (USD Million)
|
9.1.2.2. Clinical Laboratories Market Estimates and Forecast, By
Region, 2019-2029 (USD Million)
|
9.1.1. Physician
Office Laboratories
|
9.1.1.1. Physician Office
Laboratories Market Estimates and Forecast, 2019-2029 (USD Million)
|
9.1.1.2. Physician Office Laboratories Market Estimates and Forecast,
By Region, 2019-2029 (USD Million)
|
9.1.2. Others End Users
|
9.1.2.1. Others End Users Market Estimates and Forecast, 2019-2029
(USD Million)
|
9.1.2.2. Others End Users Market Estimates and Forecast, By Region,
2019-2029 (USD Million)
|
|
|
Chapter 10. Antinuclear Antibody Test Market, By Region (Market Size
and Forecast by Value - USD Million, 2018 - 2029)
|
10.1. Antinuclear Antibody
Test Market, By Region (Market Size and Forecast by Value - USD Million, 2021
& 2029)
|
10.2. North America
|
10.2.1. North
America Antinuclear Antibody Test Market, By Product Type, 2018-2029 (USD
Million)
|
10.2.2. North
America Antinuclear Antibody Test Market, By Disease Type, 2018-2029 (USD
Million)
|
10.2.3. North America Antinuclear Antibody
Test Market, By Technique, 2018-2029 (USD Million)
|
10.2.4. North
America Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD Million)
|
10.2.5. North
America Antinuclear Antibody Test Market, By Country, 2018-2029 (USD Million)
|
10.2.6. U.S.
|
10.2.6.1. U.S. Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.2.6.2. U.S. Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.2.6.3. U.S. Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.2.6.3. U.S. Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
10.2.7. Canada
|
10.2.7.1. Canada Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.2.7.2. Canada Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.2.7.3. Canada Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.2.7.3. Canada Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
|
|
10.3. Europe
|
10.3.1. Europe
Antinuclear Antibody Test Market, By Product Type, 2018-2029 (USD Million)
|
10.3.2. Europe
Antinuclear Antibody Test Market, By Disease Type, 2018-2029 (USD Million)
|
10.3.3. Europe
Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD Million)
|
10.3.4.
EuropeAntinuclear Antibody Test Market, By End Use, 2018-2029 (USD Million)
|
10.3.5. Europe Antinuclear
Antibody Test Market, By Country, 2018-2029 (USD Million)
|
10.3.6. Germany
|
10.3.6.1. Germany Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.3.6.2. Germany Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.3.6.3. Germany Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.3.6.3. Germany Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.3.7. U.K.
|
10.3.7.1. U.K. Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.3.7.2. U.K. Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.3.7.3. U.K. Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.3.7.3. U.K. Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
10.3.8. France
|
10.3.8.1.
France Antinuclear Antibody Test Market, By Product Type, 2018-2029 (USD
Million)
|
10.3.8.2. France Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.3.8.3. France Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.3.8.3. France Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.3.9. Spain
|
10.3.9.1.
Spain Antinuclear Antibody Test Market, By Product Type, 2018-2029 (USD
Million)
|
10.3.9.2. Spain Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.3.9.3.
Spain Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD Million)
|
10.3.9.3. Spain Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.3.10. Italy
|
10.3.10.1. Italy Antinuclear
Antibody Test Market, By Product Type, 2018-2029 (USD Million)
|
10.3.10.2. Italy Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.3.10.3.
Italy Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD Million)
|
10.3.10.3. Italy Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.3.11. Rest of
Europe
|
10.3.11.1. Rest of Europe
Antinuclear Antibody Test Market, By Product Type, 2018-2029 (USD Million)
|
10.3.11.2. Rest of Europe Antinuclear Antibody Test Market, By Disease
Type, 2018-2029 (USD Million)
|
10.3.11.3. Rest of
Europe Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
10.3.11.3. Rest of Europe Antinuclear Antibody Test Market, By End
Use, 2018-2029 (USD Million)
|
|
|
10.4. Asia Pacific
|
10.4.1. Asia
Pacific Antinuclear Antibody Test Market, By Product Type, 2018-2029 (USD
Million)
|
10.4.2. Asia
Pacific Antinuclear Antibody Test Market, By Disease Type, 2018-2029 (USD
Million)
|
10.4.3. Asia Pacific Antinuclear
Antibody Test Market, By Technique, 2018-2029 (USD Million)
|
10.4.4. Asia
Pacific Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD Million)
|
10.4.5. Asia
Pacific Antinuclear Antibody Test Market, By Country, 2018-2029 (USD Million)
|
10.4.6. India
|
10.4.6.1. India Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.4.6.2. India Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.4.6.3. India Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.4.6.3. India Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.4.7. Japan
|
10.4.7.1. Japan Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.4.7.2. Japan Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.4.7.3. Japan Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.4.7.3. Japan Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.4.8. China
|
10.4.8.1. China Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.4.8.2. China Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.4.8.3. China Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.4.8.3. China Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.4.9. South
Korea
|
10.4.9.1. South Korea Antinuclear Antibody Test Market, By Product
Type, 2018-2029 (USD Million)
|
10.4.9.2. South Korea Antinuclear Antibody Test Market, By Disease
Type, 2018-2029 (USD Million)
|
10.4.9.3. South Korea Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.4.9.3. South Korea Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.4.10. Australia
|
10.4.10.1. Australia Antinuclear
Antibody Test Market, By Product Type, 2018-2029 (USD Million)
|
10.4.10.2. Australia Antinuclear Antibody Test Market, By Disease
Type, 2018-2029 (USD Million)
|
10.4.10.3. Australia Antinuclear Antibody
Test Market, By Technique, 2018-2029 (USD Million)
|
10.4.10.3. Australia Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.4.11. Rest of
Asia Pacific
|
10.4.11.1. Rest of Asia Pacific Antinuclear Antibody Test Market, By
Product Type, 2018-2029 (USD Million)
|
10.4.11.2. Rest of Asia Pacific Antinuclear Antibody Test Market, By
Disease Type, 2018-2029 (USD Million)
|
10.4.11.3. Rest of Asia Pacific Antinuclear Antibody Test Market, By
Technique, 2018-2029 (USD Million)
|
10.4.11.3. Rest of Asia Pacific Antinuclear Antibody Test Market, By
End Use, 2018-2029 (USD Million)
|
|
|
10.5. Middle East &
Africa
|
10.5.1. Middle
East & Africa Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.5.2. Middle
East & AfricaAntinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
10.5.3. Middle
East & Africa Antinuclear Antibody Test Market, By Technique, 2018-2029
(USD Million)
|
10.5.4. Middle
East & Africa Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
10.5.5. Middle
East & Africa Antinuclear Antibody Test Market, By Country, 2018-2029
(USD Million)
|
10.5.6. UAE
|
10.5.6.1. UAE Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.5.6.2. UAE Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.5.6.3. UAE Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.5.6.3. UAE Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
10.5.7. Saudi
Arabia
|
10.5.7.1. Saudi Arabia Antinuclear Antibody Test Market, By Product
Type, 2018-2029 (USD Million)
|
10.5.7.2. Saudi Arabia Antinuclear
Antibody Test Market, By Disease Type, 2018-2029 (USD Million)
|
10.5.7.3. Saudi Arabia Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.5.7.3. Saudi Arabia Antinuclear
Antibody Test Market, By End Use, 2018-2029 (USD Million)
|
10.5.8. South
Africa
|
10.5.8.1. South Africa Antinuclear Antibody Test Market, By Product
Type, 2018-2029 (USD Million)
|
10.5.8.2. South Africa Antinuclear Antibody Test Market, By Disease
Type, 2018-2029 (USD Million)
|
10.5.8.3. South Africa Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.5.8.3. South Africa Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.5.9. Rest of
Middle East & Africa
|
10.5.9.1. Rest of Middle East & Africa Antinuclear Antibody Test
Market, By Product Type, 2018-2029 (USD Million)
|
10.5.9.2. Rest of Middle East & Africa Antinuclear Antibody Test
Market, By Disease Type, 2018-2029 (USD Million)
|
10.5.9.3. Rest of Middle East & Africa Antinuclear Antibody Test
Market, By Technique, 2018-2029 (USD Million)
|
10.5.9.3. Rest of Middle East & Africa Antinuclear Antibody Test
Market, By End Use, 2018-2029 (USD Million)
|
|
|
10.6. Latin America
|
10.6.1. Latin
America Antinuclear Antibody Test Market, By Product Type, 2018-2029 (USD
Million)
|
10.6.2. Latin
America Antinuclear Antibody Test Market, By Disease Type, 2018-2029 (USD
Million)
|
10.6.3. Latin
America Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
10.6.4. Latin
America Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD Million)
|
10.6.5. Latin
America Antinuclear Antibody Test Market, By Country, 2018-2029 (USD Million)
|
10.6.6. Brazil
|
10.6.6.1. Brazil Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.6.6.2. Brazil Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
10.6.6.3. Brazil Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.6.6.3. Brazil Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.6.7. Mexico
|
10.6.7.1. Mexico Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.6.7.2.
Mexico Antinuclear Antibody Test Market, By Disease Type, 2018-2029 (USD
Million)
|
10.6.7.3. Mexico Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.6.7.3. Mexico Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.6.8. Argentina
|
10.6.8.1. Argentina Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
10.6.8.2. Argentina Antinuclear Antibody
Test Market, By Disease Type, 2018-2029 (USD Million)
|
10.6.8.3. Argentina Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
10.6.8.3. Argentina Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
10.6.9. Rest of
Latin America
|
10.6.9.1. Rest of Latin America Antinuclear Antibody Test Market, By
Product Type, 2018-2029 (USD Million)
|
10.6.9.2. Rest of Latin America Antinuclear Antibody Test Market, By
Disease Type, 2018-2029 (USD Million)
|
10.6.9.3. Rest of Latin America Antinuclear Antibody Test Market, By
Technique, 2018-2029 (USD Million)
|
10.6.9.3. Rest of Latin America Antinuclear Antibody Test Market, By
End Use, 2018-2029 (USD Million)
|
|
|
Chapter 11. Competitive
Landscape
|
11.1. Market Revenue Share
by Manufacturers
|
11.2. Competitor’s
Positioning
|
11.3. Strategy Benchmarking
|
11.3.1.
Partnership & Agreement
|
11.3.2. New
Product Development
|
11.3.3. Mergers
& Acquisitions
|
11.3.4. Investment & Expansion
|
11.4. Vendor Landscape
|
11.4.1.
Distributors
|
11.4.2. North
America
|
11.4.3. Europe
|
11.4.4. Asia
Pacific
|
11.4.5. Middle
East & Africa
|
11.4.6. Latin
America
|
11.5. Zettabyte Analytics
Insights for Competitive Landscape
|
|
|
Chapter 12. Company Profiles
|
12.1. Alere Inc.(Abbott
Laboratories)
|
12.1.1. Company
Overview
|
12.1.2. Products
Offered
|
12.1.3.
Financials
|
12.1.4. Recent Development
|
12.2. Antibodies Inc.
|
12.2.1. Company
Overview
|
12.2.2. Products
Offered
|
12.2.3.
Financials
|
12.2.4. Recent Development
|
12.3. Becton Dickinson
|
12.3.1. Company
Overview
|
12.3.2. Products
Offered
|
12.3.3.
Financials
|
12.3.4. Recent
Development
|
12.4. Bio-Rad Laboratories,
Inc.
|
12.4.1. Company
Overview
|
12.4.2. Products
Offered
|
12.4.3.
Financials
|
12.4.4. Recent Development
|
12.5. BioVision Inc.
|
12.5.1. Company
Overview
|
12.5.2. Products
Offered
|
12.5.3.
Financials
|
12.5.4. Recent Development
|
12.6. ERBA Diagnostics Inc.
|
12.6.1. Company
Overview
|
12.6.2. Products
Offered
|
12.6.3.
Financials
|
12.6.4. Recent Development
|
12.7. Euroimmun AG
|
12.7.1. Company
Overview
|
12.7.2. Products
Offered
|
12.7.3.
Financials
|
12.7.4. Recent Development
|
12.8. F. Hoffmann-La Roche
Ltd.
|
12.8.1. Company
Overview
|
12.8.2. Products
Offered
|
12.8.3.
Financials
|
12.8.4. Recent Development
|
12.9. Grifols SA
|
12.9.1. Company
Overview
|
12.9.2. Products
Offered
|
12.9.3.
Financials
|
12.9.4. Recent Development
|
12.10. Immuno Concepts Inc.
|
12.10.1. Company
Overview
|
12.10.2. Products
Offered
|
12.10.3.
Financials
|
12.10.4. Recent Development
|
12.11. Inova Diagnostics
Inc.
|
12.11.1. Company Overview
|
12.11.2. Products
Offered
|
12.11.3.
Financials
|
12.11.4. Recent Development
|
12.12. Orgentec Diagnostika
GmbH
|
12.12.1. Company
Overview
|
12.12.2. Products Offered
|
12.12.3.
Financials
|
12.12.4. Recent Development
|
12.13. PerkinElmer Inc.
|
12.13.1. Company
Overview
|
12.13.2. Products
Offered
|
12.13.3.
Financials
|
12.13.4. Recent Development
|
12.14. Quidel Corporation
|
12.14.1. Company
Overview
|
12.14.2. Products
Offered
|
12.14.3.
Financials
|
12.14.4. Recent Development
|
12.15. Thermo Fisher
Scientific, Inc.
|
12.15.1. Company
Overview
|
12.15.2. Products
Offered
|
12.15.3.
Financials
|
12.15.4. Recent
Development
|
12.16. Trinity Biotech PLC
|
12.16.1. Company
Overview
|
12.16.2. Products
Offered
|
12.16.3.
Financials
|
12.16.4. Recent Development
|
12.17. Zeus Scientific,
Inc.
|
12.17.1. Company
Overview
|
12.17.2. Products
Offered
|
12.17.3.
Financials
|
12.17.4. Recent Development
|
|
|
Chapter 13. Appendix
|
13.1. Discussion guide
|
13.2. Knowledge Store: Zettabyte Analytics Subscription Portal
|
13.3. Available Customizations
|
13.4. Associated Zettabyte Analytics Reports
|
|
|
List of Tables
|
1
|
Antinuclear Antibody Test Market, By Product Type (Market Size and
Forecast by Value - USD Million, 2021 & 2029)
|
2
|
Reagents & Assay Kits Market Estimates and Forecast, 2019-2029
(USD Million)
|
3
|
Reagents & Assay Kits Market Estimates and Forecast, By Region,
2019-2029 (USD Million)
|
4
|
Systems Market Estimates and Forecast, 2019-2029 (USD Million)
|
5
|
Systems Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
6
|
Antinuclear Antibody Test Market, By Disease Type (Market Size and
Forecast by Value - USD Million, 2021 & 2029)
|
7
|
Rheumatoid Arthritis Market Estimates and Forecast, 2019-2029 (USD
Million)
|
8
|
Rheumatoid Arthritis Market Estimates and Forecast, By Region,
2019-2029 (USD Million)
|
9
|
Antinuclear Antibody Test Market, By Technique (Market Size and
Forecast by Value - USD Million, 2021 & 2029)
|
10
|
ELISA Market Estimates and Forecast, 2019-2029 (USD Million)
|
11
|
ELISA Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
12
|
Immunofluorescence Assay Market Estimates and Forecast, 2019-2029 (USD
Million)
|
13
|
Immunofluorescence Assay Market Estimates and Forecast, By Region,
2019-2029 (USD Million)
|
14
|
Multiplex Assay Market Estimates and Forecast, 2019-2029 (USD Million)
|
15
|
Multiplex Assay Market Estimates and Forecast, By Region, 2019-2029
(USD Million)
|
16
|
Antinuclear Antibody Test Market, By End Use (Market Size and Forecast
by Value - USD Million, 2021 & 2029)
|
17
|
Hospitals Market Estimates and Forecast, 2019-2029 (USD Million)
|
18
|
Hospitals Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
19
|
Clinical Laboratories Market Estimates and Forecast, 2019-2029 (USD
Million)
|
20
|
Clinical Laboratories Market Estimates and Forecast, By Region,
2019-2029 (USD Million)
|
21
|
North America Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
22
|
North America Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
23
|
North America Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
24
|
North America Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
25
|
North America Antinuclear Antibody Test Market, By Country, 2018-2029
(USD Million)
|
26
|
U.S. Antinuclear Antibody Test Market, By Product Type, 2018-2029 (USD
Million)
|
27
|
U.S. Antinuclear Antibody Test Market, By Disease Type, 2018-2029 (USD
Million)
|
28
|
U.S. Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
29
|
U.S. Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
30
|
Canada Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
31
|
Canada Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
32
|
Canada Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
33
|
Canada Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
34
|
Europe Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
35
|
Europe Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
36
|
Europe Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
37
|
EuropeAntinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
38
|
Europe Antinuclear Antibody Test Market, By Country, 2018-2029 (USD
Million)
|
39
|
Germany Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
40
|
Germany Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
41
|
Germany Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
42
|
Germany Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
43
|
U.K. Antinuclear Antibody Test Market, By Product Type, 2018-2029 (USD
Million)
|
44
|
U.K. Antinuclear Antibody Test Market, By Disease Type, 2018-2029 (USD
Million)
|
45
|
U.K. Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
46
|
U.K. Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
47
|
France Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
48
|
France Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
49
|
France Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
50
|
France Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
51
|
Spain Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
52
|
Spain Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
53
|
Spain Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
54
|
Spain Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
55
|
Italy Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
56
|
Italy Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
57
|
Italy Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
58
|
Italy Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
59
|
Rest of Europe Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
60
|
Rest of Europe Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
61
|
Rest of Europe Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
62
|
Rest of Europe Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
63
|
Asia Pacific Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
64
|
Asia Pacific Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
65
|
Asia Pacific Antinuclear Antibody Test Market, By Technique, 2018-2029
(USD Million)
|
66
|
Asia Pacific Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
67
|
Asia Pacific Antinuclear Antibody Test Market, By Country, 2018-2029
(USD Million)
|
68
|
India Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
69
|
India Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
70
|
India Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
71
|
India Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
72
|
Japan Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
73
|
Japan Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
74
|
Japan Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
75
|
Japan Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
76
|
China Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
77
|
China Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
78
|
China Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
79
|
China Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
80
|
South Korea Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
81
|
South Korea Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
82
|
South Korea Antinuclear Antibody Test Market, By Technique, 2018-2029
(USD Million)
|
83
|
South Korea Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
84
|
Australia Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
85
|
Australia Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
86
|
Australia Antinuclear Antibody Test Market, By Technique, 2018-2029
(USD Million)
|
87
|
Australia Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
88
|
Rest of Asia Pacific Antinuclear Antibody Test Market, By Product
Type, 2018-2029 (USD Million)
|
89
|
Rest of Asia Pacific Antinuclear Antibody Test Market, By Disease
Type, 2018-2029 (USD Million)
|
90
|
Rest of Asia Pacific Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
91
|
Rest of Asia Pacific Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
92
|
Middle East & Africa Antinuclear Antibody Test Market, By Product
Type, 2018-2029 (USD Million)
|
93
|
Middle East & AfricaAntinuclear Antibody Test Market, By Disease
Type, 2018-2029 (USD Million)
|
94
|
Middle East & Africa Antinuclear Antibody Test Market, By
Technique, 2018-2029 (USD Million)
|
95
|
Middle East & Africa Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
96
|
Middle East & Africa Antinuclear Antibody Test Market, By Country,
2018-2029 (USD Million)
|
97
|
UAE Antinuclear Antibody Test Market, By Product Type, 2018-2029 (USD
Million)
|
98
|
UAE Antinuclear Antibody Test Market, By Disease Type, 2018-2029 (USD
Million)
|
99
|
UAE Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
100
|
UAE Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
101
|
Saudi Arabia Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
102
|
Saudi Arabia Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
103
|
Saudi Arabia Antinuclear Antibody Test Market, By Technique, 2018-2029
(USD Million)
|
104
|
Saudi Arabia Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
105
|
South Africa Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
106
|
South Africa Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
107
|
South Africa Antinuclear Antibody Test Market, By Technique, 2018-2029
(USD Million)
|
108
|
South Africa Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
109
|
Rest of Middle East & Africa Antinuclear Antibody Test Market, By
Product Type, 2018-2029 (USD Million)
|
110
|
Rest of Middle East & Africa Antinuclear Antibody Test Market, By Disease
Type, 2018-2029 (USD Million)
|
111
|
Rest of Middle East & Africa Antinuclear Antibody Test Market, By
Technique, 2018-2029 (USD Million)
|
112
|
Rest of Middle East & Africa Antinuclear Antibody Test Market, By
End Use, 2018-2029 (USD Million)
|
113
|
Latin America Antinuclear Antibody Test Market, By Product Type,
2018-2029 (USD Million)
|
114
|
Latin America Antinuclear Antibody Test Market, By Disease Type,
2018-2029 (USD Million)
|
115
|
Latin America Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
116
|
Latin America Antinuclear Antibody Test Market, By End Use, 2018-2029
(USD Million)
|
117
|
Latin America Antinuclear Antibody Test Market, By Country, 2018-2029
(USD Million)
|
118
|
Brazil Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
119
|
Brazil Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
120
|
Brazil Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
121
|
Brazil Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
122
|
Mexico Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
123
|
Mexico Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
124
|
Mexico Antinuclear Antibody Test Market, By Technique, 2018-2029 (USD
Million)
|
125
|
Mexico Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
126
|
Argentina Antinuclear Antibody Test Market, By Product Type, 2018-2029
(USD Million)
|
127
|
Argentina Antinuclear Antibody Test Market, By Disease Type, 2018-2029
(USD Million)
|
128
|
Argentina Antinuclear Antibody Test Market, By Technique, 2018-2029
(USD Million)
|
129
|
Argentina Antinuclear Antibody Test Market, By End Use, 2018-2029 (USD
Million)
|
130
|
Rest of Latin America Antinuclear Antibody Test Market, By Product
Type, 2018-2029 (USD Million)
|
131
|
Rest of Latin America Antinuclear Antibody Test Market, By Disease
Type, 2018-2029 (USD Million)
|
132
|
Rest of Latin America Antinuclear Antibody Test Market, By Technique,
2018-2029 (USD Million)
|
133
|
Rest of Latin America Antinuclear Antibody Test Market, By End Use,
2018-2029 (USD Million)
|
134
|
Product Launch & Development in The Antinuclear Antibody Test
Market, 2018-2021
|
135
|
Investment and Expansion in The Antinuclear Antibody Test Market,
2018-2021
|
136
|
Partnership & Collaboration in The Antinuclear Antibody Test
Market, 2018-2021
|
137
|
Merger & Acquisition in The Antinuclear Antibody Test Market,
2018-2021
|
|
|
List of Figures
|
1
|
Research Methodology
|
2
|
Summary Snapshot Market Size and Forecast, USD Million, 2021 &
2029
|
3
|
Global Antinuclear Antibody Test Market Segmentation & Impact
Analysis
|
4
|
Regulatory Analysis
|
5
|
COVID-19 Impact analysis on Antinuclear Antibody Test Market
|
6
|
Market Revenue Share by Manufacturers
|
7
|
Antinuclear Antibody Test Market, By Product Type (Market Size and
Forecast by Value - USD Million, 2021 & 2029)
|
8
|
Antinuclear Antibody Test Market, By Disease Type (Market Size and
Forecast by Value - USD Million, 2021 & 2029)
|
9
|
Antinuclear Antibody Test Market, By Technique (Market Size and
Forecast by Value - USD Million, 2021 & 2029)
|
10
|
Antinuclear Antibody Test Market, By End Use (Market Size and Forecast
by Value - USD Million, 2021 & 2029)
|
11
|
Antinuclear Antibody Test Market, By Region (Market Size and Forecast
by Value - USD Million, 2021 & 2029)
|